======= POLE4 =======
== Gene Information ==
* **Official Symbol**: POLE4
* **Official Name**: DNA polymerase epsilon 4, accessory subunit
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=56655|56655]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9NR33|Q9NR33]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=POLE4&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20POLE4|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/607269|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: May play a role in allowing polymerase epsilon to carry out its replication and/or repair function.
|Histone|
|CBFD NFYB HMF|
|epsilon DNA polymerase complex|
|Ada2/Gcn5/Ada3 transcription activator complex|
|telomere maintenance via semi-conservative replication|
|DNA-directed DNA polymerase activity|
|DNA replication initiation|
|nuclear DNA replication|
|cell cycle DNA replication|
|histone H3 acetylation|
|telomere maintenance|
|telomere organization|
|DNA biosynthetic process|
|histone acetylation|
|internal peptidyl-lysine acetylation|
|G1/S transition of mitotic cell cycle|
|DNA-dependent DNA replication|
|cell cycle G1/S phase transition|
|peptidyl-lysine acetylation|
|internal protein amino acid acetylation|
|protein acetylation|
|protein acylation|
|DNA replication|
|mitotic cell cycle phase transition|
|cell cycle phase transition|
|peptidyl-lysine modification|
|anatomical structure homeostasis|
|histone modification|
|covalent chromatin modification|
|protein heterodimerization activity|
|mitotic cell cycle process|
|mitotic cell cycle|
|chromatin organization|
|DNA metabolic process|
|peptidyl-amino acid modification|
|cellular homeostasis|
|cell cycle process|
|chromosome organization|
|nucleobase-containing compound biosynthetic process|
|heterocycle biosynthetic process|
|aromatic compound biosynthetic process|
|organic cyclic compound biosynthetic process|
|cell cycle|
|DNA binding|
|cellular nitrogen compound biosynthetic process|
|homeostatic process|
|cellular macromolecule biosynthetic process|
|macromolecule biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|-2.64|
|[[:results:exp320|ABT-702 5μM plus CoCl2 18μM R07 exp320]]|-2.42|
|[[:results:exp350|Deferoxamine 11μM R07 exp350]]|-2.04|
|[[:results:exp282|Fluvastatin 2.2μM R06 exp282]]|-1.88|
|[[:results:exp270|Campthothecin 0.001μM R06 exp270]]|-1.86|
|[[:results:exp439|QNZ 0.01μM R08 exp439]]|1.9|
^Gene^Correlation^
|[[:human genes:p:pole3|POLE3]]|0.617|
|[[:human genes:c:chtf8|CHTF8]]|0.424|
|[[:human genes:c:cyb561a3|CYB561A3]]|0.404|
Global Fraction of Cell Lines Where Essential: 8/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|2/25|
|breast|0/33|
|central nervous system|1/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|3/21|
|liver|0/20|
|lung|1/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|1/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 1296
* **Expression level (log2 read counts)**: 3.46
{{:chemogenomics:nalm6 dist.png?nolink |}}